Ameditech Inc recalls 1 Step 12 Panel Cup, Item No. NBCA-12M-W These Drugs of Abuse Tests are one-step immunoassays for the qualitative detec

Recalled November 25, 2015 · FDA recall Z-0298-2016 · Ameditech

Hazard

Ameditech is recalling drug abuse tests because they have shown reduced reactivity. · FDA Class II

Units

787 kits

Sold at

Worldwide Distribution - US (nationwide) and Internationally to Australia.

Description

Ameditech is recalling drug abuse tests because they have shown reduced reactivity.

Product

1 Step 12 Panel Cup, Item No. NBCA-12M-W These Drugs of Abuse Tests are one-step immunoassays for the qualitative detection of multiple drugs and drug metabolites in human urine. The configurations of these Drugs of Abuse Tests consist of a combination of drug strips, including Benzodiazepine (BZO). They are used to obtain a visual, qualitative result and are intended for professional and point of care use.

Manufacturer(s)

Ameditech Inc

Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →